AngioDynamics (NASDAQ:ANGO) Updates FY 2025 Earnings Guidance

AngioDynamics (NASDAQ:ANGO) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share guidance of -0.380–0.340 for the period, compared to the consensus earnings per share estimate of -0.400. The company issued revenue guidance of $282.0 million-$288.0 million, compared to the consensus revenue estimate of $283.9 million.

AngioDynamics Trading Up 1.4 %

AngioDynamics stock opened at $9.40 on Wednesday. AngioDynamics has a 1-year low of $5.26 and a 1-year high of $9.63. The company has a fifty day simple moving average of $7.82 and a 200 day simple moving average of $7.27. The company has a market cap of $381.96 million, a P/E ratio of -1.54 and a beta of 0.59.

AngioDynamics (NASDAQ:ANGO) last announced its quarterly earnings data on Wednesday, January 8th. The medical instruments supplier reported ($0.04) earnings per share for the quarter, beating the consensus estimate of ($0.11) by $0.07. AngioDynamics had a negative return on equity of 5.86% and a negative net margin of 83.95%. On average, equities research analysts forecast that AngioDynamics will post -0.41 EPS for the current year.

Analyst Upgrades and Downgrades

Several research firms have recently commented on ANGO. Canaccord Genuity Group cut their price objective on AngioDynamics from $13.00 to $12.00 and set a “buy” rating for the company in a report on Friday, October 4th. HC Wainwright reiterated a “buy” rating and issued a $14.00 price target on shares of AngioDynamics in a research note on Tuesday, December 10th.

AngioDynamics Company Profile

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.